Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine

por Dayan, Gustavo H., Rouphael, Nadine, Walsh, Stephen R., Chen, Aiying, Grunenberg, Nicole, Allen, Mary, Antony, Johannes, Asante, Kwaku Poku, Bhate, Amit Suresh, Beresnev, Tatiana, Bonaparte, Matthew I, Ceregido, Maria Angeles, Dobrianskyi, Dmytro, Fu, Bo, Grillet, Marie-Helene, Keshtkar-Jahromi, Maryam, Juraska, Michal, Kee, Jia Jin, Kibuuka, Hannah, Koutsoukos, Marguerite, Masotti, Roger, Michael, Nelson L., Reynales, Humberto, Robb, Merlin L., Villagómez Martínez, Sandra M., Sawe, Fredrick, Schuerman, Lode, Tong, Tina, Treanor, John, Wartel, T. Anh, Diazgranados, Carlos A., Chicz, Roman M., Gurunathan, Sanjay, Savarino, Stephen, Sridhar, Saranya
Publicado 2023